Structural elucidation of the tetrasaccharide pool in enoxaparin sodium

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Analytical and Bioanalytical Chemistry

• Publication date

  2012-05-18

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1007/s00216-012-6045-0PMID 22610547
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comprehensive compositional analysis of heparin/heparan sulfate-derived disaccharides from human serum.

  2011cited by this paper
• Disaccharide compositional analysis of heparan sulfate and heparin polysaccharides using UV or high-sensitivity fluorescence (BODIPY) detection

  2010cited by this paper
• Structural Snapshots of Heparin Depolymerization by Heparin Lyase I*

  2009cited by this paper
• The Future of Anticoagulation

  2008cited by this paper
• Antithrombin-binding Octasaccharides and Role of Extensions of the Active Pentasaccharide Sequence in the Specificity and Strength of Interaction

  2008cited by this paper
• Low Molecular Weight Heparins: Structural Differentiation by Bidimensional Nuclear Magnetic Resonance Spectroscopy

  2007cited by this paper
• Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase.

  2005cited by this paper
• Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy.

  2005cited by this paper
• The Heparin/Heparan Sulfate 2-O-Sulfatase from Flavobacterium heparinum

  2003cited by this paper
• Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry.

  2002cited by this paper
• Emerging views of heparan sulfate glycosaminoglycan structure/activity relationships modulating dynamic biological functions.

  2002cited by this paper
• Molecular cloning of the heparin/heparan sulfate delta 4,5 unsaturated glycuronidase from Flavobacterium heparinum, its recombinant expression in Escherichia coli, and biochemical determination of its unique substrate specificity.

  2002cited by this paper
• Production and chemical processing of low molecular weight heparins.

  1999cited by this paper
• Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I.

  1998cited by this paper
• Conversion of N-sulfated glucosamine to N-sulfated mannosamine in an unsaturated heparin disaccharide by non-enzymatic, base-catalyzed C-2 epimerization during enzymatic oligosaccharide preparation.

  1998cited by this paper
• Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans.

  1998cited by this paper
• Enzymatic degradation of glycosaminoglycans.

  1995cited by this paper
• Oligosaccharide composition of heparin and low-molecular-weight heparins by capillary electrophoresis.

  1993cited by this paper
• Structure elucidation of a novel acidic tetrasaccharide and hexasaccharide derived from a chemically modified heparin.

  1993cited by this paper
• Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.

  1990cited by this paper
• Importance for Blood Anticoagulant Activity of a 2-Sulfate Grou on L-Iduronic Acid Residues in Heparin

  1989cited by this paper
• Novel regio- and stereoselective modifications of heparin in alkaline solution. Nuclear magnetic resonance spectroscopic evidence

  1989cited by this paper
• The disaccharides formed by deaminative cleavage of N-deacetylated glycosaminoglycans.

  1986cited by this paper
• Structure of the antithrombin-binding site in heparin.

  1979cited by this paper
• Correlation between structure and function of heparin.

  1979cited by this paper
• Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures.

  1976cited by this paper
• Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures.

  1976cited by this paper
• Formation of anhydrosugars in the chemical depolymerization of heparin.

  1976cited by this paper

• Fingerprinting analyses of low molecular weight heparin with an orthogonal MHC 2D LC-MS system.

  2024cites this paper
• Quality control, safety assessment and preparation approaches of low molecular weight heparin.

  2024cites this paper
• Miniaturized affinity chromatography: A powerful technique for the isolation of high affinity GAGs sequences prior to their identification by MALDI-TOF MS.

  2023cites this paper
• Saturated tetrasaccharide profile of enoxaparin. An additional piece to the heparin biosynthesis puzzle.

  2021cites this paper
• The Science and Regulations of Naturally Derived Complex Drugs

  2019cites this paper
• Scientific Considerations in the Approval of Complex Generics

  2019cites this paper
• The Evolving Mechanisms of Action of Glatiramer Acetate.

  2019cites this paper
• Recent advances in mass spectrometry analysis of low molecular weight heparins

  2018cites this paper
• Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS.

  2018cites this paper
• Carbohydrate Polymers

  2017influential citation
• Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [1H,15N] HSQC NMR

  2016influential citation
• Structural Analysis of Glycosaminoglycans—An Indispensable Tool for the Diagnosis, Treatment and Prevention of Human Disease

  2016cites this paper
• Introduction to Glycobiology and Human Diseases

  2016cites this paper
• Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2011-2012.

  2015cites this paper
• Diff erences in pharmacokinetic behaviour of branded enoxaparin and a US generic version in a non-human primate model

  2015cites this paper
• RP-IP-HPLC (reverse-phase ion-pair high-performance liquid chromatography) method for collecting enoxaparin oligosaccharide

  2014cites this paper
• Discovery of a Heparan Sulfate 3-O-Sulfation Specific Peeling Reaction

  2014cites this paper
• COMBINED NMR/LC-MS APPROACH FOR STRUCTURAL CHARACTERIZATION OF HEPARINS AND NON-ANTICOAGULANT GLYCOL-SPLIT HEPARINS

  2014cites this paper
• Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides.

  2014cites this paper
• A kind of RP-IP-HPLC method collects the method for Enoxaparin oligosaccharide

  2014cites this paper
• Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.

  2013cites this paper
• Glycosaminoglycan Structural Characterization

  2013cites this paper
• Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins.

  2013cites this paper
• Characterization of currently marketed heparin products: key tests for LMWH quality assurance.

  2013cites this paper
• Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments

  2013cites this paper
• Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides.

  2013cites this paper